|
september
11, 2025 |
Covering
Life Sciences Drugs, Diagnostics, Devices,
Digital Health |
|
|
* may need subscription to view |
|
- Calyxo: Debuts Reverse Deflection CVAC
System and Reveals Groundbreaking Two-Year
ASPIRE Data at WCET 2025, Underscoring the
Technology’s Role in Advancing Endourology More
- Charles River: Collaborates to
Enhance Oncology Manufacturing Portfolio,
Advancing Research and Development of Cell and
Gene Therapies to Treat Cancer More
- Gilead Sciences: Commits to Veeva Vault CRM
More
- Guardant Health: Expands Access to Shield
CRC Blood Test to Senior Living Communities
With LabFlorida Partnership More
- Maze Therapeutics: Positive First-in-Human
Results From Phase 1 Trial of MZE782,
Establishing Proof of Mechanism for a Potent,
Oral SLC6A19 Inhibitor With Potential to Treat
Phenylketonuria (PKU) and Chronic Kidney
Disease (CKD) More
- Personalis: CATE Clinical Trial Launched to
Demonstrate the Clinical Utility of
ctDNA-Guided Treatment in Breast Cancer Using
the Ultrasensitive NeXT Personal Test More
- Profusa: Adopts NVIDIA-Powered Technology to
Build AI-Driven Insight Portal for Continuous
Biomarker Monitoring More
- Revolution Medicines: Shares New Clinical
Results Supporting Initiation of RASolute 303,
a Global Phase 3 Registrational Trial of
Daraxonrasib in First Line Metastatic
Pancreatic Ductal Adenocarcinoma More
- Vaxart: Additional Phase 1 Data Supporting
the Potential Efficacy of Its
Second-Generation Norovirus Oral Pill Vaccine
Candidate More
- VieCure
and N-Power Medicine: Partner to Transform
Precision Medicine and Clinical Trial Access
in Community Oncology More
|
|
|
Investment Banking Advisory to the
Life Science Industry |
Learn More
→ |
|
|
- BridgeBio Pharma: Inducement Grants Under
Nasdaq Listing Rule 5635(c)(4) More
- Exclusive: A First-Time CEO Launches
Startup to Bring AI Into the Lab More*
- Exclusive VC Funding Data from BYTE51,
with Special Big4Bio Pricing More
- Maze Therapeutics: Oversubscribed $150.0
Million Private Placement More
- Mirum Pharmaceuticals: Inducement Grants
Under Nasdaq Listing Rule 5635(c)(4) More
- The Big4Bio Podcast: Surviving and
Thriving in the Long Biotech Winter Podcast
|
|
|
San
Francisco's most flexible contract
vivarium lab space: Start with a
few cages and grow. |
Learn More
→ |
|
|
- SEC Files Charges Against Former FibroGen
CMO for Manipulating Clinical Trial Data More*
- Subscribe to LifeSci Startup for
Updates on US Startups More
- 23andMe: Could Your Painful Periods Be
Endometriosis? Here’s What You Should Know More
|
|
DISCOVER COMPANIES |
Big4Bio: SFBay Life Science
Company Directory |
Locate a specific company or
explore new companies in life
science. |
Explore
our Company Directory
|
Provided courtesy
of
|
|
|
Feature your company |
Apply
to have your company
showcased by Big4Bio |
|
|
|
|
|
|
Premier Executive Search and
Talent Advisory Firm Slone
Partners Launches Fractional
Talent Service to Deliver
On-Demand Leaders and Specialists
|
Learn More
→ |
|
|
- FEATURE: The Power of Peer Learning:
Why Even Top Biotech Leaders Need Mentorship
More
- ICYMI: The Changing Landscape of Diagnostics
More
- ICYMI: CEO's Perspective: The Power of
Pivoting More
- ICYMI: What Defines Great Leadership? More
- Merck KGaA Finds Its Next R&D Leader;
Exelixis Retools Management Team As Medical
Chief Leaves More*
- Organizational Leader and Business
Strategist Kyle Kinzie Named President &
Partner More
|
|
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:SFBay,
all rights reserved 2025
© 2025
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|